Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

	Abstract	Full	Pdf
Jul 2022	1016	1064	249
Aug 2022	693	705	81
Sep 2022	500	512	117
Oct 2022	393	409	124
Nov 2022	160	160	48
Dec 2022	124	125	46
Jan 2023	119	120	28
Feb 2023	96	98	39
Mar 2023	105	105	35
Apr 2023	97	100	19
May 2023	65	67	43
Jun 2023	60	62	21
Jul 2023	60	60	29
Aug 2023	52	52	14
Sep 2023	49	50	22
Oct 2023	38	38	20
Nov 2023	49	50	27
Dec 2023	55	56	31
Jan 2024	34	34	19
Feb 2024	36	37	18
Mar 2024	56	56	65
Total	3857	3960	1095